Time to Switch to Second-line Antiretroviral Therapy in Children With Human Immunodeficiency Virus in Europe and Thailand

about

Time to Switch to Second-line Antiretroviral Therapy in Children With Human Immunodeficiency Virus in Europe and Thailand

Item

http://www.wikidata.org/entity/Q57077691

description

im Februar 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в лютому 2018

@uk

name

Time to Switch to Second-line ...... y Virus in Europe and Thailand

@en

Time to Switch to Second-line ...... y Virus in Europe and Thailand

@nl

type

Item

label

Time to Switch to Second-line ...... y Virus in Europe and Thailand

@en

Time to Switch to Second-line ...... y Virus in Europe and Thailand

@nl

prefLabel

Time to Switch to Second-line ...... y Virus in Europe and Thailand

@en

Time to Switch to Second-line ...... y Virus in Europe and Thailand

@nl

P1476

Time to Switch to Second-line ...... y Virus in Europe and Thailand

@en

P2860

Viral suppression in adolescents on antiretroviral treatment: review of the literature and critical appraisal of methodological challenges

Q27009249

Adherence to antiretroviral therapy in adolescents living with HIV: systematic review and meta-analysis

Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial.

Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial.

Long-term virological outcome in children on antiretroviral therapy in the UK and Ireland.

Pediatric response to second-line antiretroviral therapy in South Africa

Virologic failure and second-line antiretroviral therapy in children in South Africa--the IeDEA Southern Africa collaboration.

First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial.

Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in Africa.

P304

594-603

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIX854

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29029056

http://www.w3.org/2001/XMLSchema#string

P921

An Téalainn

P932

5796645

http://www.w3.org/2001/XMLSchema#string